Anesthesia Injection Franchise in Ahmedabad

Thiopental Sodium Injection Supplier in Mumbai

General Anesthetic Injection Distributor in Delhi

Critical Care Injection Manufacturer in Bangalore

Surgical Anesthesia Injection Stockist in Hyderabad
Thiopental Injection Exporter in Chandigarh

Home/Products /thiopental-sodium-1gm-injection

Thiopent 1000 Injection

Composition : Thiopental Sodium (1000mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 1gm

Price : ₹1/-

Thiopental Sodium 1000mg injection is a rapid-acting barbiturate anesthetic used for the induction of general anesthesia and short-duration surgical procedures in controlled clinical environments.

It acts by depressing the central nervous system, producing quick onset sedation and unconsciousness, making it highly effective for anesthesia induction and emergency procedural management.

This injection is commonly utilized in operative anesthesia, emergency surgeries, intensive care sedation, and seizure control in critical situations, ensuring reliable and predictable anesthetic response.

With fast onset action, dependable clinical performance, and wide acceptance in anesthesia and critical care practice, this formulation strengthens a hospital and critical care portfolio and supports consistent demand in surgical and emergency care management.

Read More

About the Product

Thiopental Sodium 1000mg injection is a rapid-acting barbiturate anesthetic used for the induction of general anesthesia and short-duration surgical procedures in controlled clinical environments.

It acts by depressing the central nervous system, producing quick onset sedation and unconsciousness, making it highly effective for anesthesia induction and emergency procedural management.

This injection is commonly utilized in operative anesthesia, emergency surgeries, intensive care sedation, and seizure control in critical situations, ensuring reliable and predictable anesthetic response.

With fast onset action, dependable clinical performance, and wide acceptance in anesthesia and critical care practice, this formulation strengthens a hospital and critical care portfolio and supports consistent demand in surgical and emergency care management.

Common side effects may include respiratory depression, hypotension, drowsiness, reduced blood pressure, slow breathing, or injection site irritation. In some cases, prolonged sedation or allergic reactions may occur. Administration should always be performed by trained healthcare professionals in a monitored clinical environment.

It helps in rapid induction of general anesthesia prior to surgical procedures and short diagnostic interventions. It is also used for short-duration anesthesia, control of refractory seizures, reduction of intracranial pressure in neurosurgical conditions, and sedation in emergency medical settings where immediate unconsciousness is required.

Thiopent 1000 Injection must be administered strictly under hospital supervision by qualified anesthesiologists or healthcare professionals. Careful monitoring of respiratory and cardiovascular functions is essential during administration. It should be used cautiously in patients with respiratory disorders, cardiovascular instability, liver impairment, or hypersensitivity to barbiturates.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep the vial tightly closed and out of reach of children. Reconstituted solution should be used immediately as per medical guidelines to maintain sterility and effectiveness.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation